Back to the program

Contributed Papers

Bayesian Applications to Clinical Trials

Tue, Aug 8, 8:30 AM

Ahmad Hakeem Abdul WahabChair

Biopharmaceutical Section

6 Presentations

A Bayesian Phase I/II Design for Cancer Clinical Trials Combining Immunotherapy and Chemotherapy

8:35 AM - 8:50 AM

Suyu Liu (UT MD Anderson Cancer Center)

Co-authors: Beibei Guo (Louisiana State University), Elizabeth Garrett-Mayer (American Society of Clinical Oncology)

Bayesian Analysis for Informing Clinical Trial Decisions in Rare Diseases

8:50 AM - 9:05 AM

Lawrence Marinucci (BioCryst Pharmaceuticals)

Co-authors: Gayan Makumburage, Heather Kopetskie (Rho, Inc.), Sharon Murray

Choice of priors for the variance parameter in Bayesian hierarchical models in clinical trials

9:05 AM - 9:20 AM

Ruoxuan Xiang (U.S. FDA)

Comparing Tolerance Intervals for Setting Acceptance Limits Under Scalar Skew-Normal Distributions

9:20 AM - 9:35 AM

Qianqiu Li (Janssen Research & Development)

Hierarchical Bayesian Modeling in Screening & Enrollment Dynamic Prediction for Clinical Trials

9:35 AM - 9:50 AM

Zhaowei Hua (Servier Pharmaceuticals, Inc.)

Co-authors: Jianmin Chen, Qian Meng (Servier Pharmaceuticals), Lucie Truffaut-Chalet (Servier), Zhaoyang Teng (Servier Pharmaceuticals), Rui Tang (Institut De Recherches Internationales Servier (I.R.I.S))

Leveraging historical data: A case study with comparison of Bayesian and frequentist approaches

9:50 AM - 10:05 AM

Zhong Gao (OBE/CBER/FDA)

Co-authors: Lihan Yan (FDA)

Session participants

Elena Polverejan (Johnson & Johnson-Janssen R&D)

Participant

↑